Electromedical Technologies, Inc.
EMED · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $588 | $1,349 | $1,150 | $907 |
| % Growth | -56.4% | 17.3% | 26.7% | – |
| Cost of Goods Sold | $207 | $303 | $261 | $199 |
| Gross Profit | $381 | $1,046 | $889 | $708 |
| % Margin | 64.8% | 77.5% | 77.3% | 78% |
| R&D Expenses | $0 | $231 | $92 | $215 |
| G&A Expenses | $0 | $2,251 | $1,904 | $3,829 |
| SG&A Expenses | $1,446 | $2,443 | $2,155 | $4,128 |
| Sales & Mktg Exp. | $0 | $192 | $251 | $300 |
| Other Operating Expenses | $0 | $436 | $245 | $165 |
| Operating Expenses | $1,446 | $3,110 | $2,492 | $4,508 |
| Operating Income | -$1,065 | -$2,065 | -$1,604 | -$3,800 |
| % Margin | -181% | -153.1% | -139.5% | -418.8% |
| Other Income/Exp. Net | -$227 | -$576 | -$1,865 | -$4,680 |
| Pre-Tax Income | -$1,292 | -$2,641 | -$3,469 | -$8,480 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,292 | -$2,641 | -$3,469 | -$8,480 |
| % Margin | -219.6% | -195.8% | -301.6% | -934.6% |
| EPS | -0.002 | -0.007 | -0.027 | -0.24 |
| % Growth | 71.4% | 73.9% | 88.8% | – |
| EPS Diluted | -0.002 | -0.007 | -0.027 | -0.24 |
| Weighted Avg Shares Out | 648,654 | 377,216 | 133,596 | 50,992 |
| Weighted Avg Shares Out Dil | 648,654 | 377,216 | 133,596 | 50,992 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $231 | $893 | $791 | $3,314 |
| Depreciation & Amortization | $48 | $26 | $22 | $22 |
| EBITDA | -$1,013 | -$1,722 | -$2,656 | -$5,144 |
| % Margin | -172.2% | -127.7% | -230.9% | -567% |